Skip to content

Study Design in Veterinary Diagnostic Evaluation

The credibility of any diagnostic claim rests on the study design behind it. This page explains the four study designs Migibio uses — and when each is appropriate.

The Four Designs

Design Question it answers Typical setup
Analytical validation Is the assay precise and accurate? Spiked samples, replicates
Diagnostic accuracy Does it detect the disease? Gold-standard comparison
Method comparison Does it agree with a reference method? Split samples, two methods
Field evaluation Does it work in the real world? Multi-site, clinical samples

Analytical Validation Design

Setup: Known-concentration samples (spiked or reference material) run in replicates.

Parameter How it is measured
LOD/LOQ Serial dilution to find the detection/quantitation floor
Precision (CV%) 20 replicates within-run and between-run
Linearity Dilution series across the claimed range
Interference Spiking with hemolysate, lipids, bilirubin

Diagnostic Accuracy Design

Setup: Clinical samples tested against a gold standard (e.g., PCR, necropsy, reference lab).

Metric Formula Meaning
Sensitivity TP/(TP+FN) Ability to detect true positives
Specificity TN/(TN+FP) Ability to avoid false positives

The gold standard must be independent of the test under evaluation — a study that uses its own assay as the gold standard proves nothing.

Method Comparison Design

Setup: The same samples run on the new method and a reference method (e.g., FICT vs ELISA), then compared by Bland-Altman and Passing-Bablok.

Field Evaluation Design

Setup: Real clinical samples across multiple sites, evaluating performance under real-world conditions (operator variability, sample quality, time constraints).

FAQ

What makes a gold standard valid? It must be independent of the test under study and recognized as definitive for the condition (e.g., PCR for viral DNA, necropsy for pathology).

Why run a field evaluation if analytical validation passed? Analytical validation uses controlled samples; field evaluation confirms the assay still performs with real-world sample quality and operator variability.

For the statistical methods, see Statistical Methods.

Authored by: Migibio Clinical & Scientific Affairs, Guangzhou Magic Biotech Co., Ltd.

Reviewed by: Migibio R&D Quality Committee

Last updated: 2026-08-13

Disclosure: Migibio (Guangzhou Magic Biotech Co., Ltd.) is the manufacturer of the FIA680/FIA880 analyzers and FICT reagents referenced in this content. See our Editorial & Review Policy.

Contact: Martin.Wong  ·  Phone (WhatsApp): +86 13323237275  ·  Email: martinwang2024@gmail.com
Back to top